Literature DB >> 30947870

The Liver in Sickle Cell Disease.

Eleni Theocharidou1, Abid R Suddle2.   

Abstract

Patients with sickle cell disease can develop liver disease as a result of intrahepatic sickling of erythrocytes, viral hepatitis and iron overload secondary to multiple blood transfusions, and gallstone disease as a result of chronic hemolysis. The spectrum of clinical liver disease is wide and often multifactorial. Some patients develop cirrhosis that may progress to end-stage liver failure. Limited evidence exists for medical treatments. Exchange blood transfusions may improve outcomes in the acute liver syndromes. Liver transplantation may be an option for chronic liver disease. The role for prophylactic cholecystectomy in preventing complications of gallstone disease is controversial. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholelithiasis; Intrahepatic cholestasis; Iron overload; Sickle cell hepatopathy; Sickle hepatic crisis; Viral hepatitis

Year:  2019        PMID: 30947870     DOI: 10.1016/j.cld.2018.12.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  11 in total

Review 1.  Management of liver complications in sickle cell disease.

Authors:  Abid R Suddle
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Pediatric Acute Liver Failure in Sickle Cell Disease.

Authors:  Luís Rodrigues; Sofia Almeida; Catarina Salgado; Cristina Gonçalves
Journal:  GE Port J Gastroenterol       Date:  2021-04-28

3.  Liver Transplantation in Patients with Sickle Cell Disease in the United States.

Authors:  Rachel Hogen; Michelle Kim; Yelim Lee; Mary Lo; Navpreet Kaur; Jeff Kahn; Shefali Chopra; Yasir Qazi; Ashraf Sedra; Jim Kim; Lauren O'Brien; Yuri Genyk; Linda Sher; Juliet Emamaullee
Journal:  J Surg Res       Date:  2020-06-12       Impact factor: 2.192

4.  Interventions for treating intrahepatic cholestasis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-06-22

5.  Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice.

Authors:  Ayla Yalamanoglu; Irina L Dubach; Nadja Schulthess; Giada Ingoglia; Delaney C Swindle; Rok Humar; Dominik J Schaer; Paul W Buehler; David C Irwin; Florence Vallelian
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 7.561

6.  Clinical-Epidemiological Characteristics and Mortality in Patients with Sickle Cell Anemia: A Retrospective Cohort Study of 1980 at 2018.

Authors:  Carolina Mariano Pompeo; Marcos Antonio Ferreira Júnior; Andreia Insabralde de Queiroz Cardoso; Mercy da Costa Souza; Oleci Pereira Frota; Felipe Machado Mota; Maria Lúcia Ivo
Journal:  Int J Gen Med       Date:  2022-02-02

7.  Sickle Cell Intrahepatic Cholestasis: Extremely Rare but Fatal Complication of Sickle Cell Disease.

Authors:  Arshan Khan; Bola Nashed; Mohamed Issa; Muhammad Zatmar Khan
Journal:  Cureus       Date:  2022-02-09

Review 8.  Sickle Hepatopathy.

Authors:  Dibya L Praharaj; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2020-08-09

9.  Acute Liver Failure in Sickle Cell Disease: A Perfect Storm.

Authors:  Nicholas B Burley; Kenneth D Miller
Journal:  Cureus       Date:  2021-06-16

10.  Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S.

Authors:  Arianna Barbetta; Cameron Goldbeck; Angelina Lim; Sean P Martin; Jeffrey A Kahn; M Raashid Sheikh; Juliet Emamaullee
Journal:  HPB (Oxford)       Date:  2021-07-06       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.